1. Home
  2. GHG vs CRBP Comparison

GHG vs CRBP Comparison

Compare GHG & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

HOLD

Current Price

$1.21

Market Cap

126.4M

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$10.90

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHG
CRBP
Founded
2004
2009
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.4M
147.4M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
GHG
CRBP
Price
$1.21
$10.90
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$45.50
AVG Volume (30 Days)
21.3K
293.5K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
4.15%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,822,272.00
Revenue This Year
$19.02
N/A
Revenue Next Year
$8.26
$116.00
P/E Ratio
$5.76
N/A
Revenue Growth
N/A
97.62
52 Week Low
$1.14
$6.73
52 Week High
$2.78
$20.56

Technical Indicators

Market Signals
Indicator
GHG
CRBP
Relative Strength Index (RSI) 45.14 63.40
Support Level $1.16 $9.32
Resistance Level $1.33 $11.64
Average True Range (ATR) 0.04 0.69
MACD -0.00 0.04
Stochastic Oscillator 20.00 75.81

Price Performance

Historical Comparison
GHG
CRBP

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: